CHIARA WILLIAMS: Open Payments
NPI 1558827014 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,018 in 254 payments from 14 companies in 2025. Trend: 2023 $685 · 2024 $1,870 · 2025 $3,018
Food & beverage: $3,018
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 90 | $626 |
| Teva Pharmaceuticals USA, Inc. | 42 | $344 |
| Supernus Pharmaceuticals, Inc. | 33 | $323 |
| Alkermes, Inc. | 15 | $311 |
| Janssen Pharmaceuticals, Inc | 11 | $275 |
| E.R. Squibb & Sons, L.L.C. | 17 | $262 |
| ABBVIE INC. | 13 | $251 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $112 |
| Luye Pharma (USA) Ltd. | 3 | $95 |
Products named: INGREZZA, Qelbree, INVEGA, ARISTADA, COBENFY, VRAYLAR, CAPLYTA, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
